BG62520B1 - Аналози на аргинина, притежаващи инхибираща активност върхуno-синтетазата - Google Patents
Аналози на аргинина, притежаващи инхибираща активност върхуno-синтетазата Download PDFInfo
- Publication number
- BG62520B1 BG62520B1 BG101942A BG10194297A BG62520B1 BG 62520 B1 BG62520 B1 BG 62520B1 BG 101942 A BG101942 A BG 101942A BG 10194297 A BG10194297 A BG 10194297A BG 62520 B1 BG62520 B1 BG 62520B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- general formula
- compound
- nitro group
- hydrogen atom
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
- C07C279/32—N-nitroguanidines
- C07C279/36—Substituted N-nitroguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9504350.1A GB9504350D0 (en) | 1995-03-04 | 1995-03-04 | Arginine derivatives |
PCT/FR1996/000337 WO1996027593A1 (fr) | 1995-03-04 | 1996-03-04 | Analogues de l'arginine ayant une activite en tant qu'inhibiteurs de la no synthase |
Publications (2)
Publication Number | Publication Date |
---|---|
BG101942A BG101942A (en) | 1999-01-29 |
BG62520B1 true BG62520B1 (bg) | 2000-01-31 |
Family
ID=10770627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG101942A BG62520B1 (bg) | 1995-03-04 | 1997-10-03 | Аналози на аргинина, притежаващи инхибираща активност върхуno-синтетазата |
Country Status (20)
Country | Link |
---|---|
US (1) | US5972940A (sk) |
EP (1) | EP0813529B1 (sk) |
JP (1) | JP3496061B2 (sk) |
KR (1) | KR19980702738A (sk) |
CN (1) | CN1071328C (sk) |
AT (1) | ATE223907T1 (sk) |
AU (1) | AU700871B2 (sk) |
BG (1) | BG62520B1 (sk) |
CA (1) | CA2215476C (sk) |
CZ (1) | CZ290747B6 (sk) |
DE (1) | DE69623602T2 (sk) |
ES (1) | ES2182964T3 (sk) |
GB (1) | GB9504350D0 (sk) |
HK (1) | HK1013777A1 (sk) |
HU (1) | HUP9801200A3 (sk) |
NZ (1) | NZ303235A (sk) |
PL (1) | PL188916B1 (sk) |
RU (1) | RU2168493C2 (sk) |
SK (1) | SK282664B6 (sk) |
WO (1) | WO1996027593A1 (sk) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003532703A (ja) * | 2000-05-05 | 2003-11-05 | ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーション・シヤンテイフイツク・(エス.セー.エール.アー.エス) | 新規アミノ酸誘導体及びその医薬としての使用 |
FR2808525A1 (fr) * | 2000-05-05 | 2001-11-09 | Sod Conseils Rech Applic | Nouveaux derives d'aminoacides et leur application a titre de medicaments |
FR2824825B1 (fr) * | 2001-05-15 | 2005-05-06 | Servier Lab | Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP1828109B1 (en) * | 2004-11-12 | 2013-06-05 | UCL Business PLC | Guanidine derivatives as inhibitors of ddah |
HU0800031D0 (en) * | 2008-01-16 | 2008-03-28 | Biotech Hungary Kutato Es Fejl | Method for stabilization of s-nitrosoglutathione and composition prepared by the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3978045A (en) * | 1973-08-13 | 1976-08-31 | Mitsubishi Chemical Industries Ltd. | N2 -dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof |
US4133880A (en) * | 1974-11-08 | 1979-01-09 | Mitsubishi Chemical Industries Ltd. | N2 -Substituted-L-arginine derivatives and the pharmaceutically acceptable acid addition salts thereof |
CA1106851A (en) * | 1975-08-08 | 1981-08-11 | Shosuke Okamoto | N.sup.2-substituted-l-arginine derivatives and the pharmaceutically acceptable acid addition salts thereof |
US5028627A (en) * | 1989-09-13 | 1991-07-02 | Cornell Research Foundation, Inc. | Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
GB8929076D0 (en) * | 1989-12-22 | 1990-02-28 | Scras | Treatment of shock by blocking agents of edrf effect or formation |
GB9200114D0 (en) * | 1992-01-04 | 1992-02-26 | Scras | Dual inhibitors of no synthase and cyclooxygenase |
US5281627A (en) * | 1992-05-28 | 1994-01-25 | Cornell Research Foundation, Inc. | Substituted arginines and substituted homoarginines and use thereof |
-
1995
- 1995-03-04 GB GBGB9504350.1A patent/GB9504350D0/en active Pending
-
1996
- 1996-03-04 DE DE69623602T patent/DE69623602T2/de not_active Expired - Lifetime
- 1996-03-04 CN CN96192885A patent/CN1071328C/zh not_active Expired - Fee Related
- 1996-03-04 AT AT96905907T patent/ATE223907T1/de not_active IP Right Cessation
- 1996-03-04 HU HU9801200A patent/HUP9801200A3/hu unknown
- 1996-03-04 US US08/913,455 patent/US5972940A/en not_active Expired - Fee Related
- 1996-03-04 CA CA002215476A patent/CA2215476C/fr not_active Expired - Fee Related
- 1996-03-04 SK SK1121-97A patent/SK282664B6/sk not_active IP Right Cessation
- 1996-03-04 PL PL96322069A patent/PL188916B1/pl not_active IP Right Cessation
- 1996-03-04 NZ NZ303235A patent/NZ303235A/xx not_active IP Right Cessation
- 1996-03-04 CZ CZ19972687A patent/CZ290747B6/cs not_active IP Right Cessation
- 1996-03-04 EP EP96905907A patent/EP0813529B1/fr not_active Expired - Lifetime
- 1996-03-04 WO PCT/FR1996/000337 patent/WO1996027593A1/fr not_active Application Discontinuation
- 1996-03-04 KR KR1019970706145A patent/KR19980702738A/ko not_active Application Discontinuation
- 1996-03-04 AU AU49479/96A patent/AU700871B2/en not_active Ceased
- 1996-03-04 RU RU97116496/04A patent/RU2168493C2/ru not_active IP Right Cessation
- 1996-03-04 ES ES96905907T patent/ES2182964T3/es not_active Expired - Lifetime
- 1996-03-04 JP JP52665796A patent/JP3496061B2/ja not_active Expired - Fee Related
-
1997
- 1997-10-03 BG BG101942A patent/BG62520B1/bg unknown
-
1998
- 1998-09-24 HK HK98110921A patent/HK1013777A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5972940A (en) | 1999-10-26 |
HK1013777A1 (en) | 1999-09-10 |
HUP9801200A2 (hu) | 1998-09-28 |
HUP9801200A3 (en) | 1998-12-28 |
EP0813529A1 (fr) | 1997-12-29 |
GB9504350D0 (en) | 1995-04-26 |
KR19980702738A (ko) | 1998-08-05 |
PL188916B1 (pl) | 2005-05-31 |
JP3496061B2 (ja) | 2004-02-09 |
WO1996027593A1 (fr) | 1996-09-12 |
CA2215476A1 (fr) | 1996-09-12 |
CN1071328C (zh) | 2001-09-19 |
CA2215476C (fr) | 2006-08-15 |
BG101942A (en) | 1999-01-29 |
SK282664B6 (sk) | 2002-11-06 |
DE69623602D1 (de) | 2002-10-17 |
RU2168493C2 (ru) | 2001-06-10 |
ES2182964T3 (es) | 2003-03-16 |
PL322069A1 (en) | 1998-01-05 |
EP0813529B1 (fr) | 2002-09-11 |
CZ290747B6 (cs) | 2002-10-16 |
JPH11501043A (ja) | 1999-01-26 |
ATE223907T1 (de) | 2002-09-15 |
AU4947996A (en) | 1996-09-23 |
AU700871B2 (en) | 1999-01-14 |
DE69623602T2 (de) | 2003-07-31 |
CZ268797A3 (cs) | 1998-07-15 |
SK112197A3 (en) | 1998-01-14 |
CN1179774A (zh) | 1998-04-22 |
NZ303235A (en) | 1999-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6048899A (en) | Anticonvulsant enantiomeric amino acid derivatives | |
JPH06239822A (ja) | 新規なn−ベンゾイルアミノ酸誘導体、これらの化合物を含有する医薬組成物およびこれらの化合物を製造する方法 | |
SU1320207A1 (ru) | Правовращающий энантиомер ( @ )- @ -этил-2-оксо-1-пирролидинацетамид,обладающий мнезической активностью | |
Greenberg et al. | Structure and dynamics of Troeger's base and simple derivatives in acidic media | |
ES2317496T3 (es) | Derivados del trifluorometilbenzamida y los usos terapeuticos de los mismos. | |
IT9021075A1 (it) | Derivati acidi benzoici sostituiti ad attivita' cardiovascolare | |
OTSUKA et al. | Synthetic studies on an antitumor antibiotic, Bleomycin. XII. Preparation of an l-2, 3-diaminopropionic acid derivative as a synthetic intermediate | |
BG62520B1 (bg) | Аналози на аргинина, притежаващи инхибираща активност върхуno-синтетазата | |
SU937450A1 (ru) | N-замещенные лактамы, про вл ющие мнезическую, антигипоксическую и сердечную активность | |
AU624978B2 (en) | N,n'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamides, preparation and their use | |
DE69131835T2 (de) | Methotrexatderivate mit antirheumatischer aktivität | |
EP0333000B1 (en) | Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them | |
SU1272982A3 (ru) | Способ получени производных пролина или их фармацевтически приемлемых солей | |
US7670784B2 (en) | β-Benzyloxyaspartic acid derivatives having two substituents on their benzene rings | |
US4525476A (en) | N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and derivatives as cognition activators | |
JPH0215067A (ja) | イソキノリンスルホンアミド誘導体 | |
Ronwin | Direct Acylation of α-Amino Acids and Dipeptides | |
US6066667A (en) | Substituted furanones, compositions and antiarthritic use | |
US4943561A (en) | Gastrin releasing peptide antagonist | |
ES2439322T3 (es) | Derivados de amino alcohol y sus actividades terapéuticas | |
DeBernardis et al. | Evaluation of the side arm of (naphthylvinyl) pyridinium inhibitors of choline acetyltransferase | |
SU1316556A3 (ru) | Способ получени производных пролина или их фармацевтически приемлемых солей | |
JPH0356462A (ja) | ピログルタミン酸誘導体 | |
US4985428A (en) | Isoxazoles with nootropic activity | |
IE41605B1 (en) | A tetrapeptide amide and acid addition salts thereof |